Click in for more news from The Hill {beacon} Health Care Health Care The Big Story 6-month HIV PrEP makes coverage gains with insurers Six months after its approval by the Food and Drug Administration (FDA), the latest advancement in HIV pre-exposure prophylaxis (PrEP) is gaining coverage from insurers initially weary of its high price tag. © Gilead Sciences...
